Key Takeaways
Shares of Tennor Therapeutics (06872.HK) more than doubled in their Hong Kong debut, closing the morning session up 135.9% at $178.6.
The biotech firm, which listed at $75.7 per share, opened for trading at $150, a 98.2% premium. The stock reached an intraday high of $193.5 and a low of $145 before its midday close. Total turnover for the half-day session was $296.46 million from 2.08 million shares traded.
The dramatic price surge indicates strong investor appetite for biotechnology firms on the Hong Kong exchange, despite a lack of specific company news driving the move. The debut performance gives the company a significant valuation premium compared to its listing price.
The strong opening performance provides a positive signal for other healthcare and biotech companies considering a Hong Kong listing. Investors will now watch if the price can maintain these levels in the full day's trading and beyond, setting a new valuation benchmark for the sector.
This article is for informational purposes only and does not constitute investment advice.
